|
|
|
|
|
|
|
|
ADPD 2013 Timetable
|
KEY:
|
PRE/POST CONFERENCE SYMPOSIUM |
CLINICAL SYMPOSIUM |
BASIC SCIENCE SYMPOSIUM |
PLENARY LECTURE |
TREATMENT STATEGIES |
*Pre-registration is required for the Informal Networking with Professor Lunch Session
* Please click here to go to the date selected:
- Tuesday, March 5, 2013
- Wednesday, March 6, 2013
- Thursday, March 7, 2013
- Friday, March 8, 2013
- Saturday, March 9, 2013
- Sunday, March 10, 2013
|
Tuesday, March 5, 2013 |
|
|
Basilica |
|
08:30-17:15 |
IMAGING SESSION
Sponsored by GE Healthcare |
Wednesday, March 6, 2013 |
|
|
Hall A |
Hall B |
Hall C |
Hall D |
|
08:30-10:30 |
Symposium 1
COGNITIVE DEFICITS IN
PRODROMAL DISEASE |
Symposium 2
ANIMAL MODELS 1 |
Symposium 3
RISK FACTORS AND EPIDEMIOLOGY
IN NEURODEGENERATIVE DISEASES |
Prion-Like Pathophysiology of Alzheimer’s Disease
Satellite Symposium Sponsored by Covance |
|
10:30 -11:00 |
Break |
|
11:00 – 13:00 |
Symposium 4
MECHANISTIC ASPECTS IN
ANIMAL MODELS |
Symposium 5
NUTRITION BASED TREATMENTS Supported by an Unrestricted Educational Grant Sponsored by Nutricia Advanced Medical Nutrition |
Symposium 6
MRI 1 |
Prion-Like Pathophysiology of Alzheimer’s Disease
Satellite Symposium Sponsored by Covance |
|
13:00 – 14:00 |
Lunch & Informal Networking with Professors* |
|
14:00 – 16:00 |
Symposium 7
MECHANISTIC ASPECTS OF AD, PD
AND FTLD |
Symposium 8
APOE –BASED TREATMENTS
AND LIPIDS |
Symposium 9
COGNITIVE DEFICITS IN
CLINICAL FEATURES: PD |
Symposium 10
INFLAMMATION IN NEURODEGENERATIVE DISEASES |
|
16:00 – 16:15 |
Break |
|
16:15 – 17:45 |
PLENARY LECTURE 1 |
|
|
|
|
PLENARY LECTURE 2 |
|
PLENARY LECTURE 3 |
|
17:45 – 18:00 |
Short Break |
|
18:00 – 19:00 |
Opening Ceremony |
|
|
|
|
19:00 |
Welcome Reception in the Exhibition Area |
Thursday, March 7, 2013 |
|
|
Hall A |
Hall B |
Hall C |
Hall D |
|
08:15-08:45 |
PLENARY LECTURE 4 |
|
|
|
|
08:45–09:00 |
Break |
|
09:00-11:00 |
Symposium 11
MITOCHONDRIA
|
Sponsored Symposium
ANTIBODY BASED IMMUNOTHERAPY
Sponsored by:
Biogen Idec
Neurimmune Holding AG |
Symposium 12
MRI 2 |
Symposium 13
ALPHA-SYNUCLEIN 1 |
|
11:00 – 11:30 |
Exhibition, Posters and Coffee Break |
|
11:30-13:30 |
Symposium 14
STEM CELLS |
Symposium 15
DZNE symposium |
Symposium 16
CLINICAL TRIAL DESIGN |
Symposium 17
APP PROCESSING AND FUNCTION |
|
13:30-14:45 |
Exhibition, Posters, Lunch & Informal Networking with Professors*
|
|
14:45-16:45 |
Symposium 18
GPCRs DRUG DISCOVERY AND DEVELOPMENT IN AD, PD, FTD |
Symposium 19
MECHANISMS OF NEURODEGENERATION 1 |
Symposium 20
BIOMARKERS 1 |
Symposium 21
PROTEIN MISFOLDING AND DEGRADATION |
|
16:45-17:15 |
Exhibition, Posters and Coffee Break
|
|
17:15-19:15 |
Symposium 22
GENETICS OF NEURODEGENERATION 1 |
Symposium 23
A-BETA TARGETED TREATMENTS
|
Symposium 24
MRI 3 |
Symposium 25
ANIMAL MODELS 2 |
|
19.20–21:20 |
Sponsored Symposium
NICOTINIC RECEPTOR AGONISTS FOR THE TREATMENT OF ALZHEIMER’S DISEASE – CURRENT CONCEPTS
Sponsored by Envivo Pharmaceuticals |
|
|
|
|
|
|
|
|
|
|
|
|
|
Friday, March 8, 2013 |
|
|
|
Hall A |
Hall B |
Hall C |
Hall D |
|
|
08:30-09:00 |
PLENARY LECTURE 5 |
|
|
|
|
|
09:00–09:15 |
Break |
|
09:15-11:15 |
Symposium 26
IMMUNOTHERAPY 1 |
Sponsored Symposium
ADVANCED TRAINING COURSE FOR DRUG DEVELOPMENT IN NEURODEGENERATIVE DISORDERS: CAN WE INCREASE THE SUCCESS?
Sponsored by QPS |
Symposium 27
BIOMARKERS 2 |
Symposium 28
MECHANISMS OF
NEURODEGENERATION 2
|
|
|
11:15-11:45 |
Exhibition, Posters and Coffee Break |
|
|
11:45-13:25 |
Sponsored Symposium
TAU AS A THERAPEUTIC TARGET IN NEURODEGENERATION
Sponsored by Axon Neuroscience SE |
|
|
|
|
|
13:25-14:45 |
Exhibition, Posters, Lunch & Informal Networking with Professors*
|
|
|
14:45-16:45 |
Symposium 29
TAU TREATMENTS |
Symposium 30
A-BETA TOXICITY OLIGOMER AND SYNAPTIC PATHOLOGY |
Symposium 31
EMERGING TREATMENTS |
Symposium 32
PET 1 |
|
|
16:45-17:15 |
Exhibition, Posters and Coffee Break
|
|
|
17:15-19:15 |
Symposium 33
DEMENTIA WITH LEWY BODIES
|
Sponsored Symposium
A NOVEL SECOND GENERATION REXINOID AGONIST IRX4204: FROM ONCOLOGY TO NEUROLOGICAL DISORDERS.
Sponsored by IO Therapeutics, Inc |
Symposium 34
BIOMARKERS 3
|
Symposium 35
LRRK AND PARKIN |
|
|
19:15-19:30 |
Break |
|
19.30 – 21:15 |
Body and Mind in Renaissance Art: Religious, Humanistic and Scientific Approaches
Monsignor Timothy Verdon
For more information, click here |
|
|
|
|
|
|
|
|
|
|
Saturday, March 9, 2013 |
|
|
Hall A |
Hall B |
Hall C |
Hall D |
|
08:30-09:00 |
PLENARY LECTURE 6 |
|
|
|
|
09:00–09:15 |
Break |
|
|
09:15-11:15 |
Symposium 36
ALPHA-SYNCLEIN 2
|
Sponsored Symposium
PGLUABETA AS TARGET FOR AD-TREATMENT BY IMMUNIZATION AND GLUTAMINYL CYCLASE INHIBITION
Sponsored by Probiodrug AG |
Symposium 37
PET 2
|
Symposium 38
PARKIN AND PROGRANULIN
|
|
11:15-11:45 |
Exhibition, Posters and Coffee Break |
|
11:45-13:25 |
Sponsored Symposium
THE AMYLOID CASCADE AND ALZHEIMER’S DISEASE: HYPOTHESIS OR THEORY?
Sponsored by Eli Lilly |
|
|
|
|
13:25-14:45 |
Exhibition, Posters, Lunch & Informal Networking with Professors |
|
14:45-16:45 |
Symposium 39
SECRETASES 1 |
Symposium 40
PRE-CLINICAL TREATMENTS |
Symposium 41
PET 3 |
Symposium 42
ALPHA-SYNUCLEIN 3 |
|
16:45-17:15 |
Exhibition, Posters and Coffee Break |
|
17:15-19:15 |
Symposium 43
TAU 1
|
Sponsored Symposium
PRECLINICAL ALZHEIMER’S DISEASE: COGNITIVE TASKS FOR EARLY DETECTION AND LOW-RISK INTERVENTIONS
Sponsored by Accera, Inc |
Symposium 44
GENETICS OF NEURODEGENERATION 2
|
Symposium 45
A-BETA TARGETED TREATMENT 2 |
|
20:15 |
ADPD Network Event |
|
|
|
|
|
|
|
|
|
|
Sunday, March 10, 2013 |
|
|
Hall A |
Hall B |
Hall C |
Hall D |
|
08:30-09:00 |
PLENARY LECTURE 7 |
|
|
|
|
09:00–09:15 |
Break |
|
09:15-11:15 |
Symposium 46
VASCULAR ASPECTS OF NEURODEGENERATION |
Symposium 47
TREATMENT STRATEGIES BASED ON NEUROPROTECTION |
Symposium 48
IMMUNOTHERAPY 2 |
Symposium 49
TAU 2 |
|
11:15-11:45 |
Coffee Break |
|
11:45-13:45 |
CLINICAL TRIALS PODIUM DISCUSSION |
Symposium 50
SECRETASES 2 |
Symposium 51
METABOLISM |
Symposium 52
ABETA AND TAU 3
|
|
13:45 |
Break |
|
13:45 – 14:15 |
Closing Ceremony |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|